Hussman Strategic Advisors’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-52,500
Closed -$274K 260
2023
Q3
$274K Buy
52,500
+37,000
+239% +$263K 0.05% 259
2023
Q2
$179K Sell
15,500
-31,000
-67% -$365K 0.03% 266
2023
Q1
$580K Hold
46,500
0.09% 261
2022
Q4
$917K Hold
46,500
0.15% 216
2022
Q3
$1.13M Sell
46,500
-15,900
-25% -$439K 0.19% 186
2022
Q2
$1.51M Hold
62,400
0.26% 147
2022
Q1
$2.02M Hold
62,400
0.39% 96
2021
Q4
$2.12M Buy
62,400
+400
+0.6% +$14.5K 0.47% 77
2021
Q3
$2.67M Buy
+62,000
New +$3.81M 0.59% 41
2021
Q2
Sell
-14,400
Closed -$756K 362
2021
Q1
$756K Sell
14,400
-47,100
-77% -$2.35M 0.16% 211
2020
Q4
$2.75M Buy
61,500
+10,850
+21% +$375K 0.72% 32
2020
Q3
$1.47M Hold
50,650
0.39% 106
2020
Q2
$1.8M Buy
50,650
+25,000
+97% +$1.05M 0.46% 91
2020
Q1
$1.32M Buy
+25,650
New +$1.23M 0.36% 114
2019
Q4
Sell
-15,000
Closed -$719K 214
2019
Q3
$719K Hold
15,000
0.2% 150
2019
Q2
$1M Hold
15,000
0.28% 131
2019
Q1
$1.43M Hold
15,000
0.35% 122
2018
Q4
$1.86M Buy
+15,000
New +$2.47M 0.45% 98

Other funds holding INGN

Hussman Strategic Advisors's INGN Position: Q4 2023 in Review

Hussman Strategic Advisors sold out of Inogen (INGN) in Q4 2023, closing a stake of 52,500 shares — an estimated $274K sold.

Hussman Strategic Advisors first reported a position in INGN in Q4 2018 and held it in 18 quarters. The position peaked at $2.75M in Q4 2020. 128 funds tracked by Wall St. Rank hold INGN as of Q4 2023.

  • Hussman Strategic Advisors reported no remaining Inogen position as of Q4 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 52,500 Inogen shares in Q4 2023, an estimated $274K.
  • Hussman Strategic Advisors first reported a position in Inogen in Q4 2018 and held it in 18 quarters.
  • Hussman Strategic Advisors's Inogen position peaked at $2.75M in Q4 2020.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q4 2023.

Based on Hussman Strategic Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.